Another Vaccine Rises, Time To Increase Asset Rotation?
Joe Quinlan, Chief Market Strategist, US Trust - BofA Private Wealth Management
17-Nov-20 07:07
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
With Moderna’s vaccine reporting an efficacy rate of 94.5% and the Dow hitting an all-time high of 30,000, is it time to change your investment plan?
The Morning Run also gets into US Treasuries, how RCEP will impact the US, and whether increased regulatory scrutiny in China is a concern for investors.
Produced by: Mike Gong
Presented by: Lyn Mak, Noelle Lim, Roshan Kanesan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Personal Finance, Investments, Financial Literacy, Politics, Law and Legal Matters, Health Policy, Diseases and Conditions, Mental Health, Healthy Living, Fitness, Science, Technology, Tech, Medical Innovation and Technology, Business Analysis, Trends and Forecasts, Markets, Social Issues
Tags: stocks, rotational plays, vaccine, moderna, dow jones, rcep, biden, alibaba, ant group, community party,
